Original Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2013; 19(47): 9012-9019
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.9012
Table 1 Incidence of gastroenteropancreatic neuroendocrine tumors according to anatomic site, sex, and the time periods 1976-1988 and 1998-2006
PeriodStomach (M/F)1Small intestine (M/F)1Pancreas (M/F)1Appendix (M/F)1Colon (M/F)1Rectum (M/F)1
1976-19780.02/0.000.11/0.150.03/0.080.20/0.350.04/0.050.01/0.01
1979-19810.04/0.030.10/0.110.07/0.0140.15/0.340.04/0.070.01/0.03
1982-19840.04/0.040.16/0.120.11/0.080.15/0.350.04/0.070.03/0.02
1985-19880.05/0.040.20/0.180.10/0.100.24/0.350.08/0.150.03/0.07
1989-1997
1998-20000.16/0.120.39/0.310.22/0.180.13/0.280.19/0.190.09/0.10
2001-20030.18/0.180.44/0.400.25/0.250.23/0.460.22/0.230.16/0.15
2004-20060.27/0.230.51/0.520.25/0.250.31/0.390.20/0.280.26/0.24
Table 2 1-, 5- and 10-year overall survival of patients with gastroenteropancreatic neuroendocrine tumors
Overall survival/periodStomachSmall intestinePancreasAppendixColonRectum
1-yr/1976-198822%30%26%95%35%50%
5-yr/1976-198811%18%11%92%16%37%
10-yr/1976-19885%10%8%90%13%37%
1-yr/1998-200671%85%74%95%68%74%
5-yr/1998-200653%68%52%86%48%65%
10-yr/1998-200643%53%35%81%34%50%